StonvexLoading…
StonvexStonvexStonvexCore line items from CNTM's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2024 2024-09-30 | Annual 2023 2023-12-31 |
|---|---|---|---|---|
Revenue | $35.84M | $22.65M | $16.38M | $19.97M |
Operating Income | $-12.59M | $-11.60M | $-5.40M | $-7.46M |
Net Income | $-16.25M | $-22.57M | $-14.74M | $-9.15M |
EPS (Diluted) | $-0.22 | $-1.18 | $-0.92 | $-0.69 |
Total Assets | $36.17M | $12.76M | Not available | $13.16M |
Total Liabilities | $34.59M | $36.54M | $32.36M | $22.64M |
Cash & Equivalents | $2.90M | $2.41M | Not available | $5.95K |
Free Cash Flow OCF − CapEx | Not available | $-5.99M | Not available | $-4.66M |
Shares Outstanding | 153.26M | 29.09M | 15.97M | 13.34M |